Applying the Nottingham Prognostic Index to a Swedish breast cancer population

被引：0
作者：
Marie Sundquist
Sten Thorstenson
Lars Brudin
Bo Nordenskjöld
机构：
[1] County Hospital,Department of Surgery
[2] County Hospital,Department of Pathology and Cytology
[3] County Hospital,Department of Clinical Physiology
[4] University Hospital,Department of Oncology
来源：
Breast Cancer Research and Treatment | 1999年 / 53卷
关键词：
breast cancer; histopathological grade; Nottingham Prognostic Index; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The aim of this study was to assess the applicability of histopathological grading according to the protocol of Elston/Ellis and the Nottingham Prognostic Index (NPI) to a defined breast cancer population. The NPI is the sum of the individual scores concerning grade, tumour size, and lymph node status, each weighted according to regression coefficients of a Cox proportional hazard analysis and calculated for each individual breast cancer patient. 630 consecutive patients with invasive breast cancer diagnosed 1988–91 were retrospectively followed up and their tumours reviewed and graded. A Cox proportional hazard analysis was performed. Grade, lymph node status, and tumour size were statistically significant predictors of survival within the follow up period (median 7.2 years). Similar to NPI, a temporary index (Kalmar Prognostic Index, KPI) was derived and normalised to NPI for comparison (KPI(norm)). NPI and KPI(norm) gave similar prognostic power in spite of the differences of the patient populations from which the 2 indices were derived. Patients with NPI 4 or less had 0.66% breast cancer specific mortality during the follow up time. 14% of the patients with NPI 4.1–5 and 32% of those with an index sum 5.1–6 died from breast cancer during this time. Younger patients tended to have higher grade tumours. We advocate the common use of grade and the NPI in order to increase the comparability of groups of patients receiving different therapies.
引用
收藏
页码：1 / 8
页数：7
相关论文
共 50 条
[31]   Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series [J].
Green, Andrew R. ;
Soria, Daniele ;
Stephen, Jacqueline ;
Powe, Desmond G. ;
Nolan, Christopher C. ;
Kunkler, Ian ;
Thomas, Jeremy ;
Kerr, Gillian R. ;
Jack, Wilma ;
Cameron, David ;
Piper, Tammy ;
Ball, Graham R. ;
Garibaldi, Jonathan M. ;
Rakha, Emad A. ;
Bartlett, John M. S. ;
Ellis, Ian O. .
JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2016, 2 (01) :32-40
[32]   Nottingham Prognostic Index Plus (NPI plus ): a modern clinical decision making tool in breast cancer [J].
Rakha, E. A. ;
Soria, D. ;
Green, A. R. ;
Lemetre, C. ;
Powe, D. G. ;
Nolan, C. C. ;
Garibaldi, J. M. ;
Ball, G. ;
Ellis, I. O. .
BRITISH JOURNAL OF CANCER, 2014, 110 (07) :1688-1697
[33]   Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer [J].
E A Rakha ;
D Soria ;
A R Green ;
C Lemetre ;
D G Powe ;
C C Nolan ;
J M Garibaldi ;
G Ball ;
I O Ellis .
British Journal of Cancer, 2014, 110 :1688-1697
[34]   Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer [J].
Andrew R. Green ;
D. Soria ;
D. G. Powe ;
C. C. Nolan ;
M. Aleskandarany ;
M. A. Szász ;
A. M. Tőkés ;
G. R. Ball ;
J. M. Garibaldi ;
E. A. Rakha ;
J. Kulka ;
I. O. Ellis .
Breast Cancer Research and Treatment, 2016, 157 :65-75
[35]   Prognostic indexes in breast cancer: comparison of the Nottingham and Adelaide indexes [J].
Sidoni, A ;
Bellezza, G ;
Cavaliere, A ;
Del Sordo, R ;
Scheibel, M ;
Bucciarelli, E .
BREAST, 2004, 13 (01) :23-27
[36]   Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution [J].
D'Eredita, G ;
Giardina, C ;
Martellotta, M ;
Natale, T ;
Ferrarese, F .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (05) :591-596
[37]   Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas [J].
Miller, DV ;
Leontovich, AA ;
Lingle, WL ;
Suman, VJ ;
Mertens, ML ;
Lillie, J ;
Ingalls, KA ;
Perez, EA ;
Ingle, JN ;
Couch, FJ ;
Visscher, DW .
MODERN PATHOLOGY, 2004, 17 (07) :756-764
[38]   Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer [J].
Kerin, Eoin P. ;
Davey, Matthew G. ;
McLaughlin, Ray P. ;
Sweeney, Karl J. ;
Barry, Michael K. ;
Malone, Carmel M. ;
Abd Elwahab, Sami ;
Lowery, Aoife J. ;
Kerin, Michael J. .
BREAST, 2022, 66 :227-235
[39]   PROLIFERATION INDEX AS A PROGNOSTIC MARKER IN BREAST-CANCER [J].
VERONESE, SM ;
GAMBACORTA, M ;
GOTTARDI, O ;
SCANZI, F ;
FERRARI, M ;
LAMPERTICO, P .
CANCER, 1993, 71 (12) :3926-3931
[40]   Thymidine labeling index: Prognostic role in breast cancer [J].
Bilir, A ;
Eralp, Y ;
Cabioglu, N ;
Agizhali, B ;
Camlica, H ;
Aydiner, A .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (04) :400-406
12345